Page last updated: 2024-11-02

pamidronate and Otosclerosis

pamidronate has been researched along with Otosclerosis in 2 studies

Otosclerosis: Formation of spongy bone in the labyrinth capsule which can progress toward the STAPES (stapedial fixation) or anteriorly toward the COCHLEA leading to conductive, sensorineural, or mixed HEARING LOSS. Several genes are associated with familial otosclerosis with varied clinical signs.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Boumans, LJ1
Poublon, RM1
Stutzmann, JJ1
Petrovic, AG1

Other Studies

2 other studies available for pamidronate and Otosclerosis

ArticleYear
The detrimental effect of aminohydroxypropylidene bisphosphonate (APD) in otospongiosis.
    European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery, 1991, Volume: 248, Issue:4

    Topics: Audiometry; Diphosphonates; Female; Hearing Loss, Bilateral; Hearing Loss, Sensorineural; Humans; Mi

1991
Diphosphonates for otospongiosis.
    The American journal of otology, 1985, Volume: 6, Issue:1

    Topics: Adult; Bone Development; Bone Resorption; Clodronic Acid; Diphosphonates; Etidronic Acid; Humans; Ma

1985